|
1.
|
Rosen AB, Aizcorbe A, Ryu AJ, Nestoriak N, Cutler DM, Chernew ME. Policy makers will need a way to update bundled payments that reflects highly skewed spending growth of various care episodes. Health Aff (Millwood). 2013 May; 32(5):944-51.
|
|
|
|
|
2.
|
Pirraglia PA, Hampton JM, Rosen AB, Witt WP. Psychological distress and trends in healthcare expenditures and outpatient healthcare. Am J Manag Care. 2011 May; 17(5):319-28.
|
|
|
|
|
3.
|
Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010 Sep; 5(7):406-9.
|
|
|
|
|
4.
|
Greenberg D, Rosen AB, Wacht O, Palmer J, Neumann PJ. A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006. Med Decis Making. 2010 May-Jun; 30(3):320-7.
|
|
|
|
|
5.
|
Heisler M, Choi H, Rosen AB, Vijan S, Kabeto M, Langa KM, Piette JD. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care. 2010 Feb; 48(2):87-94.
|
|
|
|
|
6.
|
Chernew ME, Juster IA, Shah M, Wegh A, Rosenberg S, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. Evidence that value-based insurance can be effective. Health Aff (Millwood). 2010 Mar-Apr; 29(3):530-6.
|
|
|
|
|
7.
|
Stewart ST, Cutler DM, Rosen AB. Forecasting the effects of obesity and smoking on U.S. life expectancy. N Engl J Med. 2009 Dec 3; 361(23):2252-60.
|
|
|
|
|
8.
|
Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009 Oct 14; 302(14):1573-9.
|
|
|
|
|
9.
|
Rosen AB, Spaulding AB, Greenberg D, Palmer JA, Neumann PJ. Patient adherence: a blind spot in cost-effectiveness analyses? Am J Manag Care. 2009 Sep; 15(9):626-32.
|
|
|
|
|
10.
|
Rosen AB, Cutler DM. Challenges in building disease-based national health accounts. Med Care. 2009 Jul; 47(7 Suppl 1):S7-13.
|
|
|
|
|
11.
|
Spaulding A, Fendrick AM, Herman WH, Stevenson JG, Smith DG, Chernew ME, Parsons DM, Bruhnsen K, Rosen AB. A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trial. Implement Sci. 2009; 4:19.
|
|
|
|
|
12.
|
Stewart ST, Woodward RM, Rosen AB, Cutler DM. The impact of symptoms and impairments on overall health in US national health data. Med Care. 2008 Sep; 46(9):954-62.
|
|
|
|
|
13.
|
Chernew M, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, Fendrick AM. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med. 2008 Aug; 23(8):1131-6.
|
|
|
|
|
14.
|
Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Fendrick AM. Confronting hysteria: a reply to Fairman and Curtiss. J Manag Care Pharm. 2008 Apr; 14(3):324-6; author reply 326-8.
|
|
|
|
|
15.
|
Langa KM, Larson EB, Karlawish JH, Cutler DM, Kabeto MU, Kim SY, Rosen AB. Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement. 2008 Mar; 4(2):134-44.
|
|
|
|
|
16.
|
Chernew ME, Shah MR, Wegh A, Rosenberg SN, Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. Impact of decreasing copayments on medication adherence within a disease management environment. Health Aff (Millwood). 2008 Jan-Feb; 27(1):103-12.
|
|
|
|
|
17.
|
Braithwaite RS, Rosen AB. Linking cost sharing to value: an unrivaled yet unrealized public health opportunity. Ann Intern Med. 2007 Apr 17; 146(8):602-5.
|
|
|
|
|
18.
|
Brauer CA, Neumann PJ, Rosen AB. Trends in cost effectiveness analyses in orthopaedic surgery. Clin Orthop Relat Res. 2007 Apr; 457:42-8.
|
|
|
|
|
19.
|
Chernew ME, Rosen AB, Fendrick AM. Value-based insurance design. Health Aff (Millwood). 2007 Mar-Apr; 26(2):w195-203.
|
|
|
|
|
20.
|
Rosen AB, Cutler DM, Norton DM, Hu HM, Vijan S. The value of coronary heart disease care for the elderly: 1987-2002. Health Aff (Millwood). 2007 Jan-Feb; 26(1):111-23.
|
|
|
|
|
21.
|
Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006 Aug 31; 355(9):920-7.
|
|
|
|
|
22.
|
Brauer CA, Rosen AB, Greenberg D, Neumann PJ. Trends in the measurement of health utilities in published cost-utility analyses. Value Health. 2006 Jul-Aug; 9(4):213-8.
|
|
|
|
|
23.
|
Rosen AB. Grounding coverage in value: a paradigm for linking quality and costs. Med Care. 2006 May; 44(5):389-91.
|
|
|
|
|
24.
|
Rosen AB. Indications for and utilization of ACE inhibitors in older individuals with diabetes. Findings from the National Health and Nutrition Examination Survey 1999 to 2002. J Gen Intern Med. 2006 Apr; 21(4):315-9.
|
|
|
|
|
25.
|
Chernew ME, Rosen AB, Fendrick AM. Rising out-of-pocket costs in disease management programs. Am J Manag Care. 2006 Mar; 12(3):150-4.
|
|
|
|
|
26.
|
Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ. Bias in published cost effectiveness studies: systematic review. BMJ. 2006 Mar 25; 332(7543):699-703.
|
|
|
|
|
27.
|
Neumann PJ, Lin PJ, Greenberg D, Berger M, Teutsch S, Mansley E, Weinstein MC, Rosen AB. Do drug formulary policies reflect evidence of value? Am J Manag Care. 2006 Jan; 12(1):30-6.
|
|
|
|
|
28.
|
Neumann PJ, Rosen AB, Weinstein MC. Medicare and cost-effectiveness analysis. N Engl J Med. 2005 Oct 6; 353(14):1516-22.
|
|
|
|
|
29.
|
Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S. Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005 Jul 19; 143(2):89-99.
|
|
|
|
|
30.
|
Rosen AB, Greenberg D, Stone PW, Olchanski NV, Neumann PJ. Quality of abstracts of papers reporting original cost-effectiveness analyses. Med Decis Making. 2005 Jul-Aug; 25(4):424-8.
|
|
|
|
|
31.
|
Neumann PJ, Rosen AB, Greenberg D, Olchanski NV, Pande R, Chapman RH, Stone PW, Ondategui-Parra S, Nadai J, Siegel JE, Weinstein MC. Can we better prioritize resources for cost-utility research? Med Decis Making. 2005 Jul-Aug; 25(4):429-36.
|
|
|
|
|
32.
|
Stone PW, Schackman BR, Neukermans CP, Olchanski N, Greenberg D, Rosen AB, Neumann PJ. A synthesis of cost-utility analysis literature in infectious disease. Lancet Infect Dis. 2005 Jun; 5(6):383-91.
|
|
|
|
|
33.
|
Brauer CA, Rosen AB, Olchanski NV, Neumann PJ. Cost-utility analyses in orthopaedic surgery. J Bone Joint Surg Am. 2005 Jun; 87(6):1253-9.
|
|
|
|
|
34.
|
Rosen AB, Blendon RJ, DesRoches CM, Benson JM, Bates DW, Brodie M, Altman DE, Zapert K, Steffenson AE, Schneider EC. Physicians' views of interventions to reduce medical errors: does evidence of effectiveness matter? Acad Med. 2005 Feb; 80(2):189-92.
|
|
|
|
|
35.
|
Neumann PJ, Greenberg D, Olchanski NV, Stone PW, Rosen AB. Growth and quality of the cost-utility literature, 1976-2001. Value Health. 2005 Jan-Feb; 8(1):3-9.
|
|
|
|
|
36.
|
Sonnad SS, Greenberg D, Rosen AB, Neumann PJ. Diffusion of published cost-utility analyses in the field of health policy and practice. Int J Technol Assess Health Care. 2005; 21(3):399-402.
|
|
|
|
|
37.
|
Pirraglia PA, Rosen AB, Hermann RC, Olchanski NV, Neumann P. Cost-utility analysis studies of depression management: a systematic review. Am J Psychiatry. 2004 Dec; 161(12):2155-62.
|
|
|
|
|
38.
|
Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med. 2004 Jun; 19(6):669-75.
|
|
|
|
|
39.
|
Greenberg D, Rosen AB, Olchanski NV, Stone PW, Nadai J, Neumann PJ. Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis. BMJ. 2004 Jun 26; 328(7455):1536-7.
|
|
|
|
|
40.
|
Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004 Apr; 19(4):332-8.
|
|
|
|
|
41.
|
Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol. 2004 Jan 15; 93(2):247-50.
|
|
|
|
|
42.
|
Rosen AB, Tsai JS, Downs SM. Variations in risk attitude across race, gender, and education. Med Decis Making. 2003 Nov-Dec; 23(6):511-7.
|
|
|
|
|
43.
|
Blendon RJ, DesRoches CM, Brodie M, Benson JM, Rosen AB, Schneider E, Altman DE, Zapert K, Herrmann MJ, Steffenson AE. Views of practicing physicians and the public on medical errors. N Engl J Med. 2002 Dec 12; 347(24):1933-40.
|
|
|
|
|
44.
|
Peterson ED, DeLong ER, Muhlbaier LH, Rosen AB, Buell HE, Kiefe CI, Kresowik TF. Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol. 2000 Dec; 36(7):2174-84.
|
|
|
|
|
45.
|
Mullen G, Napier J, Balestra M, DeCory T, Hale G, Macor J, Mack R, Loch J, Wu E, Kover A, Verhoest P, Sampognaro A, Phillips E, Zhu Y, Murray R, Griffith R, Blosser J, Gurley D, Machulskis A, Zongrone J, Rosen A, Gordon J. (-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. J Med Chem. 2000 Nov 2; 43(22):4045-50.
|
|
|
|
|
46.
|
Rosen AB, Fowler VG, Corey GR, Downs SM, Biddle AK, Li J, Jollis JG. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med. 1999 May 18; 130(10):810-20.
|
|
|
|
|
47.
|
Hebert JR, Rosen A. Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. Cancer Detect Prev. 1996; 20(3):234-44.
|
|
|
|
|
48.
|
Sorensen G, Rigotti NA, Rosen A, Pinney J, Prible R. Employee knowledge and attitudes about a work-site nonsmoking policy: rationale for further smoking restrictions. J Occup Med. 1991 Nov; 33(11):1125-30.
|
|
|
|
|
49.
|
Sorensen G, Rosen A, Pinney J, Rudolph J, Doyle N. Work-site smoking policies in small businesses. J Occup Med. 1991 Sep; 33(9):980-4.
|
|
|
|
|
50.
|
Sorsensen G, Rigotti N, Rosen A, Pinney J, Prible R. Effects of a worksite nonsmoking policy: evidence for increased cessation. Am J Public Health. 1991 Feb; 81(2):202-4.
|
|
|
|
